EXOME PRO analyzes the coding regions of the genome — the part where most clinically actionable variants are found.
It is the most common first-line test.
GENOME PRO analyzes the entire genome, including non-coding regions, structural variants and complex genomic architecture.
It is recommended when a broader genomic view is appropriate.
Both tests include the same clinical interpretation framework developed for rare disease diagnostics at Breda Genetics.
Your genome contains information that may shape future medical decisions — for you and for the family you may build.
A clinically structured predictive analysis clarifies actionable health risks and reproductive carrier status, while defining what remains uncertain.
Rare disease:
a diagnosis that explains the past.
Predictive testing:
information that reshapes the future.
Predictive genomics is not the search for zero risk.
It is the acceptance that some risk can be clarified — and some cannot.
Choosing to know is not an act of fear.
It is an act of responsibility toward your future decisions.
Predictive genomic analysis turns genetic variation into clinically interpretable risk.
Inheritance is statistical.
Until it becomes personal.
Risk operates on two levels.
Individual Risk
Predictive analysis evaluates medically actionable variants that may influence long-term health decisions.
Results are interpreted within clinical context, family history, and established evidence.
Reproductive Risk
Every individual carries recessive pathogenic variants — typically five to eight — without clinical symptoms.
When evaluated within a couple, carrier status defines the probability of transmitting a recessive condition to offspring.
Depth through clinical interpretation
Sequencing reveals genetic variation.
Clinical judgment defines meaning.
Massive data are generated.
Expertise filters what truly matters — defining real personal and reproductive risk.
Genomic expertise lies in both identifying meaningful variants and knowing which ones to ignore.
The clinical pathway
Predictive genomic analysis begins with a dedicated clinical consultation.
During this discussion, the scope of the analysis, its potential outcomes, and its limitations are carefully defined.
Results are interpreted within a clinical framework and returned through genetic counselling — ensuring that complex genomic information becomes meaningful medical insight.
Pricing:
EXOME PRO — 1,990 €
GENOME PRO — 3,950 €
Genetic consultation required prior to testing.